Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawada, S.
Right arrow Articles by Hirschl, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawada, S.
Right arrow Articles by Hirschl, R. B.
(Chest. 2002;121:566-572.)
© 2002 American College of Chest Physicians

Effects of Partial Liquid Ventilation on Unilateral Lung Injury in Dogs*

Shigeki Sawada, MD; Kenichi Matsuda, MD; John G. Younger, MD; Kent J. Johnson, MD; Robert H. Bartlett, MD, FCCP and Ronald B. Hirschl, MD, FCCP

* From the Departments of Surgery (Drs. Sawada, Matsuda, Bartlett, and Hirschl), Emergency Medicine (Dr. Younger), and Pathology (Dr. Johnson), University of Michigan Medical Center, Ann Arbor, MI.

Correspondence to: Ronald B. Hirschl, MD, FCCP, F3970 Mott Hospital Box 0245, University of Michigan Medical Center, Ann Arbor, MI 48109-0245; e-mail: rhirschl{at}umich.edu


    Abstract
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Study objective: The overall physiologic effect of partial liquid ventilation (PLV) in the setting of unilateral lung injury remains unclear. Therefore, we evaluated the effect of PLV on gas exchange in unilateral lung injury.

Design and methods: Left unilateral lung injury was induced in 14 adult dogs by oleic acid instillation into a left pulmonary artery. The animals were divided into two groups: gas ventilation (GV) and PLV. During both GV and PLV, systemic blood gas levels were analyzed. Oxygen consumption (O2), carbon dioxide production (CO2) and pulmonary blood flow (Q) of both the right lung (uninjured lung) and left lung (injured lung) were measured.

Results: During PLV, O2 of the injured left lung (o2-injured), CO2 of the injured left lung (CO2-injured), and Q of the injured left lung (Q-injured) were greater than those in GV (O2-injured, 41.6 mL/min vs 23.4 mL/min, p = 0.006; CO2-injured, 34.4 mL/min vs 25.5 mL/min, p = 0.026; and Q-injured, 0.47 L/min vs 0.22 L/min, p = 0.002, respectively). However, overall PaO2 during PLV was less than that during GV, likely due to either a redistribution of Q toward the injured lung (PLV Q-injured, 0.47 L/min vs GV Q-injured, 0.22 L/min; p = 0.002) or reduced gas exchange efficiency in the healthy lung.

Conclusions: We conclude that in our model, PLV increases O2 and VCO2 in the injured lung. However, over all gas exchange efficiency is reduced.

Key Words: carbon dioxide production • oleic acid • partial liquid ventilation • perflubron • unilateral lung injury


    Introduction
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Many animal and human studies1 2 3 4 5 have demonstrated the ability of partial liquid ventilation (PLV) to support or improve gas exchange in the setting of respiratory failure. However, it has also been observed that PLV results in a deterioration in gas exchange in normal lungs.6 7 8 9 10 Syndromes associated with asymmetrical or unilateral lung injury caused by aspiration pneumonia, pulmonary hemorrhage, and pulmonary edema are occasionally observed clinically. In addition, the use of PLV for lavaging the unilaterally injured lung has been considered. However, the overall physiologic effect of PLV on gas transport in such a setting with one injured lung and one healthy lung remains unclear. In fact, there is concern that administration of perflubron in such patients may actually diminish gas exchange. With this study, therefore, we intended to evaluate the effect of PLV on gas exchange in the setting of unilateral lung injury. We developed the following hypotheses prior to performing the experiments: (1) gas exchange is improved overall during PLV in the setting of unilateral lung injury, (2) gas exchange is enhanced in the injured lung and reduced in the healthy lung, and (3) pulmonary blood flow (Q) is redistributed from the healthy to the injured lung during PLV in the setting of unilateral lung injury.


    Materials and Methods
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animal Preparation
A cohort of 14 adult healthy heartworm-free dogs weighing 20.8 ± 0.6 kg (mean ± SE) were anesthetized with a 25 mg/kg IV pentobarbital sodium injection. A midline neck incision and a tracheotomy were performed. A 35F double-lumen Carlens endotracheal tube (Rusch; Duluth, GA) was placed. After intubation, mechanical ventilation was performed with a fraction of inspired oxygen (FIO2) of 1.0, a tidal volume of 15 mL/kg (right lung, 8 mL/kg; left lung, 7 mL/kg), and positive end-expiratory pressure of 5 cm H2O using a double-piston ventilator (model 818; Harvard Apparatus; South Natick, MA). The PaCO2 was maintained between 34 mm Hg and 46 mm Hg by adjusting the respiratory rate. Anesthesia was maintained by intermittent bolus injections of pentobarbital sodium, 130 mg, when tachycardia and hypertension were observed. Pancuronium bromide, 0.1 mg/kg, was administered every hour to maintain paralysis. After induction of anesthesia, a 7F pulmonary arterial catheter was advanced through the external jugular vein to measure pulmonary arterial pressures, for administration of medications, and for mixed venous blood gas measurements. An arterial line was placed in the carotid artery to measure arterial pressure and for arterial blood gas assessment. After placement of catheters, a left thoracotomy was performed. Both left and right pulmonary arteries were isolated, and 6 mm and 12 mm in diameter flow probes (Transonic Systems; Ithaca, NY) were placed around the left and right pulmonary arteries, respectively. The right pulmonary flow (Q of the uninjured right lung [Q-uninjured]) and the left pulmonary flow (Q of the injured left lung [Q-injured]) were recorded. Cardiac output (Qt) was calculated as the sum of right and left pulmonary flows. The left mainstem bronchus was isolated, and the tip of the double-lumen endotracheal tube was advanced into the left mainstem bronchus by manual palpation. The tip was secured in position by tying an umbilical tape externally around the bronchus and endotracheal tube tip. The left lung was inflated to make sure that the left upper bronchus was not obstructed by the tube. The left thoracotomy was then closed with a chest tube placed to 10 cm H2O of suction.

Thirty minutes following closure of the thoracotomy, the baseline data indicated below were recorded. Heparin, 1,500 U, was administered systemically along with 200 mL of lactated Ringer’s solution. Unilateral lung injury was induced by administration of oleic acid, 0.08 mL/kg, into the left pulmonary artery, while the right pulmonary artery was clamped via temporary reopening of the anterolateral thoracotomy incision. Prior to administration, oleic acid, 0.08 mL/kg, was diluted with 20 mL of blood and 500 U of heparin and then injected slowly with continuous shaking of the syringe via the proximal port of the pulmonary artery catheter over 10 min. The right pulmonary artery was maintained clamped for 2 min after completion of the oleic acid administration. The left thoracotomy was then closed as a thoracostomy tube was placed. Lactated Ringer’s solution was infused at a constant rate of 100 mL/h via the proximal port of the pulmonary artery catheter throughout the study period.

Experimental Design
Following data collection at the point of lung injury, the animals were divided into two groups. In the first group (n = 7), gas ventilation (GV) was performed for 2 h. In the second group (n = 7), PLV was performed in both the right and left lungs for 2 h. The 2-h time period was chosen to follow a 90-min period of lung injury development since, in our experience, it is adequate to evaluate a stable effect of ventilation strategy in the acute oleic acid lung injury model.

GV was performed using a Harvard double-piston ventilator with each limb of the double-lumen tube connected to one of the pistons. The ventilator was set as described above throughout the experiment. PLV was performed by introducing perflubron (LiquiVent; Alliance Pharmaceutical Corporation; San Diego, CA) via both the right and left endotracheal tubes during temporary endotracheal tube disconnect. Perflubron was administered until a meniscus was observed in the both endotracheal tubes at the anterior chest level. The total volume of perflubron administered was 439 ± 9 mL (250 ± 9 mL in the right lung and 188 ± 6 mL in the left lung) initially (mean ± SEM). PLV with gas ventilation was then performed in similar fashion to the GV-treated animals. Additional perflubron was administrated every hour to maintain a similar liquid meniscus present. PLV was performed in both lungs simultaneously in order to simulate the clinical application of PLV in the setting of a unilateral lung injury.

Data were obtained at the following time points: baseline, 90 min following administration of oleic acid (injury), and every hour for the duration of the 2-h study (post 1 and post 2). At the conclusion of the experiment, all animals were killed with an overdose of pentobarbital sodium. Postmortem examination was performed on all dogs to confirm the presence of unilateral lung injury. A lung specimen was obtained from the anterior, middle, and dependent lung segments of both the right and left lungs, and fixed with 10% formaldehyde for histologic analysis.

Outcome Measures
Spirometric measurements of individual lung oxygen consumption (O2) were accomplished at each data point by intermittently connecting a device (Fig 1 ) to the distal tip (left injured lung) or side port lumen (right uninjured lung) of the endotracheal tube. The device circuit and spirometer were flushed with 100% oxygen, and the entire system was pressurized by placing a 500-g weight on the top of the spirometer in order to demonstrate that the system was leak free. The device was then connected to one lumen of the endotracheal tube, and ventilation of that lung was initiated using a bellows in a box connected to the Harvard ventilator. A NaHCO3 scrubber was placed in the circuit to remove expired carbon dioxide. O2 was evaluated by measurement of the volume loss from the spirometer in the closed circuit. The average volume loss per minute was measured over a 5-min period.



View larger version (17K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1. Spirometric measurement of O2. PEEP = positive end-expiratory pressure.

 
Individual lung carbon dioxide production (CO2) was assessed by collecting expired gas from each lung into a spirometer that allowed assessment of minute ventilation volume. The average minute ventilation volume was determined over a 2-min period. A capnometer (HP-47210A; Hewlett Packard; Waltham, MA) was placed between the mixing chamber and the spirometer and used to determine the mixed expiratory carbon dioxide level. The capnometer was calibrated before each preparation. CO2 for each lung was calculated based on the following equation:

CO2 and O2 were corrected to standard temperature and pressure, dry and for the vapor pressure of perflubron at 37°C.

At each data point, mean arterial pressure, mean pulmonary artery pressure, individual peak inspiratory pressures, along with ventilator rate and FIO2 were assessed with a pressure monitor (HP-78901A; Hewlett-Packard). Right and left pulmonary artery flow rates were recorded by the flow probes. Arterial and mixed venous blood samples were analyzed by an ABL-520 blood gas analyzer and OSM-3 Co-oximeter (Radiometer Copenhagen; Copenhagen, Denmark). Core body temperature was recorded via the pulmonary artery catheter thermistor. Intrapulmonary shunt (Qs/Qt) was calculated by the following equation:

where Qps = physiologic shut; CaO2 = oxygen content of arterial blood; CvO2 = oxygen content of mixed venous blood; and CiO2 = oxygen content of the blood draining from the ideal alveolus ventilated with gas (FIO2 = 1.0) as derived from the alveolar gas equation and the oxygen dissociation curve.

Data Analysis
The within-group effect of oleic acid administration was compared between the data points of baseline and injury with paired t tests. The effect of PLV in the setting of unilateral lung injury was compared between the GV-treated and PLV-treated groups using a two-way repeated analysis of variance across the post-1 and post-2 data points. Comparisons were considered to be significant when the p values were < 0.05. Data are demonstrated as mean ± SEM.


    Results
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
All dogs survived the duration of the experiment. Postmortem examinations confirmed that the left lungs of all dogs demonstrated external evidence of lung edema, hemorrhage, and dependent atelectasis, while the right lungs appeared pink and well inflated. Representative biopsy specimens from the upper right lung and upper left lung in the GV-treated group are shown in Figure 2 . The right lung specimen shows mild interstitial pneumonitis with neutrophils, and the left lung specimen shows much more severe injury with focal parenchymal necrosis, interstitial and alveolar infiltration, fibrin deposition, and focal hemorrhage.



View larger version (75K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2. Right and left lungs from the GV-treated group (hematoxylin-eosin, original x 40).

 
Physiologic Data
Physiologic data are shown in Table 1 . Injured lung peak inspiratory pressure significantly increased after oleic acid administration in both the GV-treated and PLV-treated animals (p = 0.030 and p = 0.004, respectively). Mean pulmonary pressure increased after oleic acid administration in both the GV group and the PLV group, but not in a statistically significant fashion (p = 0.111 and p = 0.294, respectively). Initiation of PLV did not change heart rate, mean arterial pressure, or mean pulmonary arterial pressure in the PLV group when compared to the GV group at the post-1 and post-2 data points.


View this table:
[in this window]
[in a new window]

 
Table 1. Various Experimental Physiologic Data*

 
Gas Exchange
PaCO2, PaO2 and Qs/Qt data are demonstrated in Figure 3 . After oleic acid administration, impaired gas exchange was reflected as hypoxia and hypercarbia at the injury data point, while Qs/Qt was not statistically significantly changed. Although the GV-treated animals remained hypercarbic for the period of the experiment, their oxygenation gradually improved. In contrast, over the same time period, the oxygenation and Qs/Qt worsened in the PLV-treated group.



View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3. Graphs of PaO2, PaCO2, and Qs/Qt. *, p < 0.05 when the baseline and injury data points are compared within the groups. {dagger}, p < 0.05 when the post-1 and post-2 data points are compared between the groups. Data are presented as mean ± SEM.

 
Q
Qt, Q-uninjured, Q-injured, and proportion of left lung flow to total flow (Q-injured/Qt) are demonstrated in Figure 4 . Qt significantly decreased after administration of oleic acid (p = 0.003, GV group; p = 0.001, PLV group). After initiation of PLV, Q-injured in the PLV group increased significantly when compared to that in the GV group without any change in Q-uninjured (p = 0.002). This was associated with an increase in Q-injured/Qt in the PLV group when compared to the GV group (p = 0.002).



View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4. Graphs of Qt, individual pulmonary artery flows, and Q-injured/Qt. *, p < 0.05 when baseline and injury data points are compared within the groups. {dagger}, p < 0.05 when the post-1 and post-2 data points are compared between the groups. Data are presented as mean ± SEM.

 
O2 and CO2
Gas exchange was also compared by evaluating changes in individual lung gas exchange as demonstrated in Figure 5 . In both groups, O2 in the injured left lung (O2-injured) decreased and O2 in the uninjured right lung (O2-uninjured) increased significantly after induction of lung injury. Subsequently, O2-injured of the PLV group significantly increased when compared to that of the GV group at the post-1 and post-2 data points (p = 0.006). The proportion of O2-injured to total O2 (O2T) of both groups decreased significantly after oleic acid administration (GV, p = 0.008; PLV, p = 0.010). Following initiation of PLV, O2-injured/O2T of the PLV group significantly increased when compared to that of the GV group at the post-1 and post-2 data points (p = 0.004).



View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5. Graphs of O2T, individual O2, and o2-injured/O2T. *, p < 0.05 when baseline and injury data points are compared within the groups. {dagger}, p < 0.05 when post-1 and post-2 data points are compared between the groups. Data are presented as mean ± SEM.

 
Similar results were observed for CO2 (Fig 6 ). CO2 in the injured left lung (CO2-injured) and the proportion of VCO2-injured to total CO2 (CO2T) in both groups decreased significantly after induction of lung injury (GV VCO2-injured: GV, p = 0.014; PLV, p = 0.050; CO2-injured/CO2T: GV, p = 0.008; PLV, p = 0.010). However CO2-injured and CO2-injured/CO2T of the PLV-treated group significantly increased when compared to the GV at the post-1 and post-2 data points (CO2-injured, p = 0.026; CO2-injured/CO2T, p = 0.009).



View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6. Graphs of CO2T, individual CO2, and CO2-injured/CO2T. *, p < 0.05 when baseline and injury data points are compared within the groups. {dagger}, p < 0.05 when post-1 and post-2 data points are compared between the groups. Data are presented as mean ± SEM.

 

    Discussion
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A number of studies1 2 3 4 5 have evaluated the ability of PLV to provide gas exchange in normal animals and in the setting of lung injury. Such studies have, however, evaluated the efficacy of PLV in the setting of bilateral lung injury. A number of studies6 7 8 9 10 have suggested that the ventilation/perfusion matching during PLV is such that oxygenation is limited in the normal lung. Thus, liquid ventilation might adversely affect gas exchange if it were to be performed in the setting of unilateral lung injury. There are no studies, of which we are aware, that have undertaken to evaluate the physiologic effects of PLV in the setting of unilateral lung injury. In this present study, unilateral lung injury was induced by left pulmonary arterial injection of oleic acid, which has been documented to increase pulmonary vascular permeability, and mimics the effects of fat embolism.11 12 Gross lung autopsy and biopsy data suggest that a severe unilateral lung injury was indeed achieved. A dose of 0.08 mL/kg of oleic acid was administered to induce left unilateral lung injury. This dose is approximately 0.4 that of the normal oleic acid dose that is used in many lung injury models, since the volume of the left lung is approximately 40% of the total lung volume.13 14

Oleic acid induces an acute lung injury associated with an increase in pulmonary vascular permeability and thrombosis with resulting acute lung edema and elevated pulmonary vascular resistance (PVR).12 14 We speculate that the increase in PVR may have been the cause of the decrease in Q-injured/Qt. However, it is also important to note that Qt also decreased, which may be due to an effect of oleic acid on cardiac function.13 The decrease in blood flow to the injured left lung may also have been secondary to the development of hypoxic pulmonary vasoconstriction associated with atelectasis or lung injury.16 It is likely that one or both of these phenomena increased PVR and decreased Q-injured. After initiation of PLV, both O2-injured and VCO2-injured increased in the PLV-treated group, which confirmed our hypothesis. However, we were surprised to note that the systemic PaO2 decreased and the Qs/Qt increased following initiation of PLV. During the period of PLV, Q was redistributed from the uninjured lung to the injured lung. It appears that either performance of PLV resulted in a reduction in gas exchange in the right (uninjured) lung or that the redistribution of Q toward the left (injured) lung resulted in a greater proportion of blood flow through a lung with inefficient gas exchange. Either way, the overall effect was a decrease in PaO2 and an increase in Qs/Qt.

It is interesting to speculate on the etiology of the redistribution of Q toward the injured left lung during PLV. One possible mechanism is resolution of local hypoxia in the injured left lung during PLV with reopening of vessels constricted due to regional hypoxia. Aly et al15 measured PVR in oleic acid-injured piglets and demonstrated a decrease in PVR presumably due to resolution of hypoxic pulmonary vasoconstriction during PLV in an oleic acid lung injury model. In contrast, PVR may increase in the normal lung since gas transfer may deteriorate during PLV. In addition, an increase in PVR may be affected due to a hydrodynamic effect of the heavy perfluorocarbon in the lungs, since the volume of perfluorocarbon may be increased in the well-inflated, healthy lung when compared to the atelectatic, injured lung, resulting in a greater effect on PVR in one lung vs the other.

Although the PaO2 decreased and the Qs/Qt increased during the period of PLV in our model, PLV did not have a substantial detrimental effect on oxygen delivery in the setting of unilateral lung injury. In addition, it should be realized that there may be advantages to performing PLV in the setting of unilateral lung injury, especially with the potential ability of the liquid to lavage and to evacuate exudate out of the airways and to recruit lung regions. In addition, there is mounting evidence that perfluorocarbon may reduce lung injury, decrease neutrophil infiltration, and modulate the neutrophil and macrophage inflammatory response.17 18 19 20

It is possible that a reperfusion injury may have occurred in the right lung due to clamping of the right pulmonary artery. However, the period of pulmonary artery clamp application was short (10 min) and was not accompanied by discontinuation of bronchial artery flow. In any event, histology of the right lung only demonstrated mild pneumonitis that could also have been associated with other factors, such as mechanical ventilation for > 3.5 h.

We conclude from these data that in our model of acute unilateral lung injury that PLV is associated with an increase in O2 and CO2 in the injured lung and a redistribution of pulmonary arterial blood flow toward the injured lung. This is associated with an overall decrease in PaO2 and increase in Qs/Qt. PLV should be applied cautiously, therefore, in the setting of unilateral lung injury, although the advantages of its lung lavage and recruiting capabilities may make its use in this setting worthwhile.


    Footnotes
 
Abbreviations: FIO2 = fraction of inspired oxygen; PLV = partial liquid ventilation; GV = gas ventilation; O2 = oxygen consumption; o2-injured = O2 of the injured left lung; O2T = total oxygen consumption; CO2 = carbon dioxide production; CO2-injured = CO2 of the injured left lung; CO2T = total carbon dioxide production; PVR = pulmonary vascular resistance; Q = pulmonary blood flow; Q-injured = pulmonary blood low of the injured left lung; Q-uninjured = Q of the uninjured right lung; Qt = cardiac output; Qs/Qt = intrapulmonary shunt

Supported by National Institutes of Health grant No. R29-HL57224 and the Alliance Pharmaceutical Corporation.

Received for publication December 20, 2000. Accepted for publication July 15, 2001.


    References
 TOP
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Wilcox, DT, Glick, PL, Fuhrman, BP (1995) Perfluorocarbon-associated gas exchange improves pulmonary mechanics, oxygenation, ventilation, and allows nitric oxide delivery in the hypoplastic lung congenital diaphragmatic hernia lamb model. Crit Care Med 23,1858-1863[CrossRef][ISI][Medline]
  2. Papo, MC, Paczan, PR, Fuhrman, BP, et al (1996) Perfluorocarbon-associated gas exchange improves oxygenation, lung mechanics, and survival in a model of adult respiratory distress syndrome. Crit Care Med 24,466-474[CrossRef][ISI][Medline]
  3. Richman, PS, Wolfson, MR, Shaffer, TM (1993) Lung lavage with oxygenated perfluorochemical liquid in acute lung injury. Crit Care Med 21,768-774[ISI][Medline]
  4. Hirschl, RB, Overbeck, MC, Parent, A (1994) Liquid ventilation provides uniform distribution of perfluorocarbon in the setting of respiratory failure. Surgery 116,159-168[ISI][Medline]
  5. Gauger, PG, Overbeck, MC, Koeppe, RA, et al (1997) Distribution of pulmonary blood flow and total lung water during partial liquid ventilation in acute lung injury. Surgery 122,313-323[CrossRef][ISI][Medline]
  6. Shaffer, TH, Moskowitz, GD (1974) Demand-control liquid ventilation of the lungs. J Appl Physiol 36,208-213[Free Full Text]
  7. Koen, PA, Wolfson, MR, Shaffer, TH (1988) Fluorocarbon ventilation: maximal expiratory flows and CO2 elimination. Pediatr Res 24,291-296[ISI][Medline]
  8. Wolfson, MR, Greenspan, JS, Deoras, KS, et al (1992) Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates. J Appl Physiol 72,1024-1031[Abstract/Free Full Text]
  9. Kylstra, JA, Paganelli, CV, Lanphier, EH (1966) Pulmonary gas exchange in dogs ventilated with hyperbarically oxygenated liquid. J Appl Physiol 21,177-184[Free Full Text]
  10. Tutuncu, AS, Houmes, RJ, Bos, JA, et al (1996) Evaluation of lung function after intratracheal perfluorocarbon administration in healthy animals. Crit Care Med 24,274-279[CrossRef][ISI][Medline]
  11. Halden, E, Hedstrand, U, Torsner, K (1982) Oleic acid lung damage in pigs. Acta Anesth Scand 26,121-125[Medline]
  12. Schoene, RB, Robertson, HT, Thorning, DR, et al (1984) Pathophysiological pattern of resolution from acute oleic acid injury in the dog. J Appl Physiol 56,472-481[Abstract/Free Full Text]
  13. Curtis, SE, Peek, JT, Kelly, DR (1993) Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. J Appl Physiol 75,2696-2702[Abstract/Free Full Text]
  14. Schuster, DP, Perez, JE, Trulock, PE, et al (1986) Cardiac dysfunction during acute lung injury induced by oleic acid in dogs. Am Rev Respir Dis 133,519-525[Medline]
  15. Aly, H, Lueders, M, Weiswasser, J, et al (1997) Partial liquid ventilation (PLV) and lung injury: is PLV able to modify pulmonary vascular resistance? J Pediatr Surg 32,197-202[Medline]
  16. Takeda, K, Knapp, MJ, Wolfe, WG, et al (1987) Hypoxia enhances unilateral lung injury by increasing blood flow to the injured lung. J Appl Physiol 63,2516-2523[Abstract/Free Full Text]
  17. Totta, AT, Steinhorm, DM (1998) Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. Crit Care Med 26,1707-1715[CrossRef][ISI][Medline]
  18. Colton, DM, Till, GO, Johnson, KJ, et al (1998) Neutrophil accumulation is reduced during partial liquid ventilation. Crit Care Med 26,1716-1724[CrossRef][ISI][Medline]
  19. Younger, JG, Taqi, AS, Till, GO, et al (1997) Partial liquid ventilation protects lung during resuscitation from shock. J Appl Physiol 83,1666-1670[Abstract/Free Full Text]
  20. Bradley, JD, Soppner, ML, Rusheen, PD, et al (1996) Intratracheal perflubron (PFB) reduces lung myeloperoxidase (MPO) levels following cobra venom factor (CVF) challenge in rats [abstract]. FASEB J 626,A108




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawada, S.
Right arrow Articles by Hirschl, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawada, S.
Right arrow Articles by Hirschl, R. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS